1. Immunogenicity of therapeutic proteins: clinical implications and future prospects;Schellekens;Clin. Ther.,2002
2. Scientific and regulatory considerations on the immunogenicity of biologics;Shankar;Trends Biotechnol.,2006
3. Committee for Medicinal Products for Human Use (CHMP). Guideline on Immunogenicity Assessment of Biotechnology-Derived Therapeutic Proteins EMEA/CHMP/BMWP/14327/2006;European Agency for the Evaluation of Medicinal Products (EMEA),2008
4. Guidance for Industry: Assay Development for Immunogenicity Testing of Therapeutic Proteins;U.S. Department of Health and Human Services,2009
5. Strategies for detection, measurement and characterization of unwanted antibodies induced by therapeutic biologicals;Wadhwa;JIM,2003